Does CAPMATINIB Cause Oedema peripheral? 247 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Oedema peripheral have been filed in association with CAPMATINIB (TABRECTA). This represents 10.7% of all adverse event reports for CAPMATINIB.
247
Reports of Oedema peripheral with CAPMATINIB
10.7%
of all CAPMATINIB reports
25
Deaths
43
Hospitalizations
How Dangerous Is Oedema peripheral From CAPMATINIB?
Of the 247 reports, 25 (10.1%) resulted in death, 43 (17.4%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPMATINIB. However, 247 reports have been filed with the FAERS database.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
Decreased appetite (95)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which CAPMATINIB Alternatives Have Lower Oedema peripheral Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN